A- A A+

Treatment for opioid use disorder in the Florida medicaid population: Using a cascade of care model to evaluate quality.

Johnson K, Hills H, Ma J, Brown CH, McGovern M.

Am J Drug Alcohol Abuse. 2021 Mar 4;47(2):220-228. doi: 10.1080/00952990.2020.1824236. Epub 2020 Oct 15. PMID: 33054435; PMCID: PMC8046836.


Neuseeland. Opioid addicts waiting two years for help in Southland and Otago 

Southern opioid addicts have to wait two years for opioid substitution treatment because the program is underfunded. (Stuff, neusseland, 07.08.2021)


Contingency Management Programme Team. Using a pragmatically adapted, low-cost contingency management intervention to promote heroin abstinence in individuals undergoing treatment for heroin use disorder in UK drug services (PRAISE): a cluster randomised trial. 

Metrebian N, Weaver T, Goldsmith K, Pilling S, Hellier J, Pickles A, Shearer J, Byford S, Mitcheson L, Bijral P, Bogdan N, Bowden-Jones O, Day E, Dunn J, Glasper A, Finch E, Forshall S, Akhtar S, Bajaria J, Bennett C, Bishop E, Charles V, Davey C, Desai R, Goodfellow C, Haque F, Little N, McKechnie H, Mosler F, Morris J, Mutz J, Pauli R, Poovendran D, Phillips E, Strang J; 

BMJ Open. 2021 Jul 1;11(7):e046371. doi: 10.1136/bmjopen-2020-046371. PMID: 34210725; PMCID: PMC8252884.


HIV and overdoses: diversifying therapies for opioid use disorder

Waters, Richard C et al.

The Lancet, Volume 398, Issue 10302, 741 - 742 


Evaluation of a Digital Health Initiative in Illicit Substance Use: Cross-sectional Survey Study. 

Kershaw S, Birrell L, Deen H, Newton NC, Stapinski LA, Champion KE, Kay-Lambkin F, Teesson M, Chapman C. 

J Med Internet Res. 2021 Aug 10;23(8):e29026. doi: 10.2196/29026. PMID: 34383690; PMCID: PMC8386404.


Potential Effects of Digital Inequality on Treatment Seeking for Opioid Use Disorder. 

Garett R, Young SD. 

Int J Ment Health Addict. 2021 Aug 27:1-6. doi: 10.1007/s11469-021-00629-5. Epub ahead of print. PMID: 34466133; PMCID: PMC8395375.


Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials. 

Klimas J, Hamilton MA, Gorfinkel L, Adam A, Cullen W, Wood E. 

Syst Rev. 2021 Aug 6;10(1):216. doi: 10.1186/s13643-021-01764-9. PMID: 34362464; PMCID: PMC8348786.


Improving Treatment Together: a protocol for a multi-phase, community-based participatory, and co-design project to improve youth opioid treatment service experiences in British Columbia. 

Marchand K, Tallon C, Katan C, Fairbank J, Fogarty O, Pellatt KM, Turuba R, Mathias S, Barbic S. 

Addict Sci Clin Pract. 2021 Aug 14;16(1):53. doi: 10.1186/s13722-021-00261-7. PMID: 34391483; PMCID: PMC8364413.


Rapid situational assessment of people who inject drugs (PWID) in Nairobi and coastal regions of Kenya: a respondent driven sampling survey. 

Oguya FO, Kenya PR, Ongecha F, Mureithi P, Musyoka H, Muraguri N, Mundia B, Angira C, Shose M, Basheeb TA, Mohamed AA, Oyore JP, Ochieng OG, Dida GO, Abdalla S, Abdool R. 

BMC Public Health. 2021 Aug 14;21(1):1549. doi: 10.1186/s12889-021-11373-9. PMID: 34391389; PMCID: PMC8364050.


Predictors of retention in the treatment for opioid dependence: A prospective, observational study from India. 

Shouan A, Ghosh A, Singh SM, Basu D, Mattoo SK.

Indian J Psychiatry. 2021 Jul-Aug;63(4):355-365. doi: 10.4103/psychiatry.IndianJPsychiatry_448_20. Epub 2021 Aug 7. PMID: 34456348; PMCID: PMC8363890.


Coercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, Canada. 

Pilarinos A, Barker B, Nosova E, Milloy MJ, Hayashi K, Wood E, Kerr T, DeBeck K. 

Addiction. 2020 Jan;115(1):97-106. doi: 10.1111/add.14769. Epub 2019 Sep 6. PMID: 31379008; PMCID: PMC6933075.


Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder. 

Weintraub E, Seneviratne C, Anane J, et al. 

JAMA Netw Open. 2021;4(8):e2118487. doi:10.1001/jamanetworkopen.2021.18487


The Helping to End Addiction Long-term (HEAL) Initiative of the National Institutes of Health. 

Baker RG, Koroshetz WJ, Volkow ND. 

JAMA. Published online August 26, 2021. doi:10.1001/jama.2021.13300


Partnering With State Health Departments to Address Injection-Related Infections During the Opioid Epidemic: Experience at a Safety Net Hospital. 

Burns RH, Pierre CM, Marathe JG, Ruiz-Mercado G, Taylor JL, Kimmel SD, Johnson SL, Fukuda HD, Assoumou SA. 

Open Forum Infect Dis. 2021 Apr 27;8(8):ofab208. doi: 10.1093/ofid/ofab208. PMID: 34409120; PMCID: PMC8364760.


USA. First Opinion: Medically, legally, and morally, emergency departments cannot ignore addiction care

(…) The treatment a person receives in an emergency department can often make the difference between life and death. This is particularly true for people with addiction. Yet far too many emergency departments fail to provide essential evidence-based and lifesaving care for these patients.

That must change. Hospital emergency departments have an obligation to provide equitable care for all patients. Addiction is a treatable, medical illness. When patients come to emergency departments for overdose or other addiction-related health crises, hospitals can and must provide the evidence-based interventions that are backed by data, recommended by federal agencies, and endorsed by medical associations like the American College of Emergency Physicians, which this summer published consensus guidelines on treating opioid use disorder in the emergency department that one of us (G.D.) helped write. (Sika Yeboah-Sampong andGail D'Onofrio in: Stat News, USA, 13.08.2021)


USA. "How To" Webinar - Expanding Use of Mobile Vans

AATOD produced a webinar on August 11, 2021, which described how OTPs can expand their blueprint throughout the country by expanding the use of mobile vans. The Drug Enforcement Administration released its final regulation on June 28, 2021, which went into effect on July 28, 2021. (AATOD - American Association for the Treatment of Opioid Dependence, 12.08.2021)


Changes in methadone take-home dosing before and after COVID-19 [published online ahead of print, 2021 Jun 24]. 

Amram O, Amiri S, Thorn EL, Lutz R, Joudrey PJ. 

J Subst Abuse Treat. 2021;108552. doi:10.1016/j.jsat.2021.108552


Characterizing the Clinical use of a Novel Video-assisted Dosing Protocol With Secure Medication Dispensers to Reduce Barriers to Opioid Treatment. 

Brooklyn JR, Stothart M, Stunell M, Berman VM, Rylant D, Hanson M. 

J Addict Med. 2021 Jul 16. doi: 10.1097/ADM.0000000000000895. Epub ahead of print. PMID: 34282084.


Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder. 

Parlier-Ahmad AB, Pugh M Jr, Martin CE. 

J Racial Ethn Health Disparities. 2021 Jul 12:1–11. doi: 10.1007/s40615-021-01095-4. Epub ahead of print. PMID: 34254271; PMCID: PMC8274965.


Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems. 

Bagley SM, Chavez L, Braciszewski JM, Akolsile M, Boudreau DM, Lapham G, Campbell CI, Bart G, Yarborough BJH, Samet JH, Saxon AJ, Rossom RC, Binswanger IA, Murphy MT, Glass JE, Bradley KA; PROUD Collaborative. 

Addict Sci Clin Pract. 2021 Jul 7;16(1):46. doi: 10.1186/s13722-021-00249-3. PMID: 34233750; PMCID: PMC8262000.


Financial sustainability of payment models for office-based opioid treatment in outpatient clinics. 

Hodgkin D, Horgan C, Bart G. 

Addict Sci Clin Pract. 2021 Jul 5;16(1):45. doi: 10.1186/s13722-021-00253-7. PMID: 34225785; PMCID: PMC8256208.


Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment. 

Busch AB, Greenfield SF, Reif S, Normand ST, Huskamp HA. 

J Subst Abuse Treat. 2020 Aug;115:108040. doi: 10.1016/j.jsat.2020.108040. Epub 2020 May 22. PMID: 32600627; PMCID: PMC7687676.


“It’s like ‘liquid handcuffs”: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients’ lives. 

Frank, D., Mateu-Gelabert, P., Perlman, D.C. et al.

Harm Reduct J 18, 88 (2021). doi.org/10.1186/s12954-021-00535-y


Patient Satisfaction with Telemedicine in Addictions

Mayet S., Arshad S., McCaw I., Hashmani Z., Drozdova Z., Gledhill A., Shahbaz S., and Phillips T.

Heroin Addiction and Related Clinical Problems, Published Ahead of Print, August 2, 2021


Treatment of opium addiction in persian medicine: A review study. 

Kamali M, Kamali H, Doustmohammadi M, Sheikhbardsiri H, Moghadari M. 

J Educ Health Promot. 2021 May 20;10:157. doi: 10.4103/jehp.jehp_5_21. PMID: 34222532; PMCID: PMC8224515.


USA. The New Mobile Methadone Rules And What They Mean For Treatment Access

Mobile narcotic treatment programs (or vans that travel to multiple locations to deliver methadone treatment) are one strategy to increase access to evidence-based treatment for underserved populations and improve treatment retention. These mobile methadone vans could help marginalized populations, including Black people and people of color, access medications for opioid use disorders. Mobile delivery of methadone could also help provide incarcerated persons, people residing in rural communities, or those with transportation difficulties access to methadone treatment that would otherwise be out of reach. (Health Affairs, USA, 04.08.2021)


Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state. 

Bogan C, Jennings L, Haynes L, Barth K, Moreland A, Oros M, Goldsby S, Lane S, Funcell C, Brady K. 

J Subst Abuse Treat. 2020 Mar;112S:73-78. doi: 10.1016/j.jsat.2020.02.007. PMID: 32220414; PMCID: PMC8115203.


Factors affecting addiction severity index (ASI) among clients enrolled in methadone maintenance treatment (MMT) program in Myanmar. 

Tun, S., Vicknasingam, B. & Singh, D. 

Harm Reduct J 18, 84 (2021). https://doi.org/10.1186/s12954-021-00523-2


USA. “How To” Webinar – Expanding the Use of Mobile Vans

AATOD produced a webinar, which described how OTPs can expand their blueprint throughout the country by expanding the use of mobile vans. The Drug Enforcement Administration released its final regulation on June 28, 2021, which went into effect on July 28, 2021. (AATOD - American Association for the Treatment of Opioid Dependence, 13.08.2021)


USA. New York Initiative Reduces Barriers to Opioid Use Disorder Treatment 

Ithaca-based program to evaluate components of its comprehensive service delivery model. (PEW Trusts, USA, 26,07.2021)